Euclidean Capital
Euclidean Capital reported 10 stocks worth $324M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are VEU (83.2%), INDA (5.3%) and ORIC (4.1%). Compared with Q2 2026, the fund opened new positions in MRLN and sold out of VTV and SRZN.
Latest filing: what Euclidean Capital did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() VEU Vanguard Intl Equity Index F | $269M | 83.2% | 3.2M | No change | 8 of 8 | |
| 2 | ![]() INDA Ishares TR | $17.3M | 5.3% | 370K | No change | 8 of 8 | |
| 3 | ![]() ORIC Oric Pharmaceuticals Inc | $13.3M | 4.1% | 989K | No change | 8 of 8 | |
| 4 | ![]() TMS Teamshares Inc | $8M | 2.5% | 1.1M | No change | 2 of 8 | |
| 5 | ![]() FHTX Foghorn Therapeutics Inc | $5.6M | 1.7% | 1.6M | No change | 8 of 8 | |
| 6 | ![]() PMVP Pmv Pharmaceuticals Inc | $4.4M | 1.4% | 2.6M | No change | 8 of 8 | |
| 7 | ![]() SRZN Surrozen Inc | $2.8M | 0.9% | 88K | No change | 8 of 8 | |
| 8 | ![]() ALEC Alector Inc | $2.4M | 0.8% | 1.3M | No change | 8 of 8 | |
| 9 | ![]() TNYA Tenaya Therapeutics Inc | $613K | 0.2% | 1M | No change | 8 of 8 | |
| 10 | ![]() MRLN Merlin Inc | $90K | 0.0% | 48K | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() VTV Vanguard Index Fds | $113M | 520K |
![]() SRZN Surrozen Inc | $3K | 171K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Euclidean Capital 13F FAQ
What does Euclidean Capital own?
Euclidean Capital reported 10 stocks worth $324M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are VEU (83.2%), INDA (5.3%) and ORIC (4.1%). The table above lists every position in the filing (the top 10 without an account).
What did Euclidean Capital buy and sell in Q3 2026?
Compared with Q2 2026: 1 new positions, 0 added to, 0 trimmed and 2 sold out. New positions include MRLN. It sold all of VTV and SRZN.
When will Euclidean Capital file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Euclidean Capital's portfolio worth?
The Q3 2026 filing reports $324M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.










